Whitehawk Therapeutics Inc

WHWK · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$52,615$73,016-$18,273
Dep. & Amort.$16$57$47
Deferred Tax$0$0$0
Stock-Based Comp.$3,087$1,680$1,854
Change in WC-$3,447$733$833
Other Non-Cash$2-$87,350$486
Operating Cash Flow-$52,957-$11,864-$15,053
Investing Activities
PP&E Inv.-$1-$551-$186
Net Acquisitions$0$101,356$0
Inv. Purchases-$32,215$0$1
Inv. Sales/Matur.$3,390$14,693$13,318
Other Inv. Act.$0$0$0
Investing Cash Flow-$28,826$115,498$13,133
Financing Activities
Debt Repay.$0$0$0
Stock Issued-$850$100,002$0
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$0-$4,801$53
Financing Cash Flow-$850$95,201$53
Forex Effect$0$0$0
Net Chg. in Cash-$82,633$198,835-$1,867
Supplemental Information
Beg. Cash$227,569$28,734$30,601
End Cash$144,936$227,569$28,734
Free Cash Flow-$52,958-$12,415-$15,239
Whitehawk Therapeutics Inc (WHWK) Financial Statements & Key Stats | AlphaPilot